Use access key #2 to skip to page content.
$46.09 -0.16 (-0.35%)
7/23/2008 4:03 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
***

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar boca7rel (59.11) Submitted: 5/26/07 3:08 PM : Outperform Start Price: $51.05 AZN Score: 5.91

cheap earnings compared to industry sector. Low debt to equity ratio

Report this Post Replies: 0 | Reply

Featured Broker Partners